2021
DOI: 10.1016/j.biotechadv.2021.107864
|View full text |Cite
|
Sign up to set email alerts
|

Biotechnological applications of type 1 secretion systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 13 publications
(21 citation statements)
references
References 127 publications
0
21
0
Order By: Relevance
“…[ 4 , 5 ] Recombinant protein secretion is beneficial over intracellular production strategies to meet biotechnological purposes because of various reasons such as simplifying downstream processes, reducing risk of cytosolic degradation, higher quality and solubility of secreted protein, avoidance of inclusion body formation, and reduced costs of production processes. [ 5 , 6 , 7 ]…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…[ 4 , 5 ] Recombinant protein secretion is beneficial over intracellular production strategies to meet biotechnological purposes because of various reasons such as simplifying downstream processes, reducing risk of cytosolic degradation, higher quality and solubility of secreted protein, avoidance of inclusion body formation, and reduced costs of production processes. [ 5 , 6 , 7 ]…”
Section: Introductionmentioning
confidence: 99%
“…Attempts to achieve reasonable secretion levels for recombinant protein secretion have been continuously made commonly with limited success, presumably due to the complexity of the multi‐component secretion machineries. [ 6 , 7 , 9 ]…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations